GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » EV-to-EBITDA

Angelalign Technology (HKSE:06699) EV-to-EBITDA : 106.80 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Angelalign Technology's enterprise value is HK$8,081 Mil. Angelalign Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil. Therefore, Angelalign Technology's EV-to-EBITDA for today is 106.80.

The historical rank and industry rank for Angelalign Technology's EV-to-EBITDA or its related term are showing as below:

HKSE:06699' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.63   Med: 39.9   Max: 283.34
Current: 106.8

During the past 6 years, the highest EV-to-EBITDA of Angelalign Technology was 283.34. The lowest was 10.63. And the median was 39.90.

HKSE:06699's EV-to-EBITDA is ranked worse than
94.67% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.145 vs HKSE:06699: 106.80

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Angelalign Technology's stock price is HK$68.90. Angelalign Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.350. Therefore, Angelalign Technology's PE Ratio for today is 196.86.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Angelalign Technology EV-to-EBITDA Historical Data

The historical data trend for Angelalign Technology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology EV-to-EBITDA Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 82.60 46.96 35.21

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.60 - 46.96 - 35.21

Competitive Comparison of Angelalign Technology's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Angelalign Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's EV-to-EBITDA falls into.



Angelalign Technology EV-to-EBITDA Calculation

Angelalign Technology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8080.560/75.662
=106.80

Angelalign Technology's current Enterprise Value is HK$8,081 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Angelalign Technology  (HKSE:06699) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Angelalign Technology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=68.90/0.350
=196.86

Angelalign Technology's share price for today is HK$68.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Angelalign Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.350.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Angelalign Technology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Angelalign Technology (HKSE:06699) Business Description

Traded in Other Exchanges
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Angelalign Technology (HKSE:06699) Headlines

No Headlines